We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
+5.3%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$1.57B
AUM Growth
-$357M
Cap. Flow
-$378M
Cap. Flow %
-24.03%
Top 10 Hldgs %
33.66%
Holding
618
New
154
Increased
58
Reduced
119
Closed
276

Top Sells

Rank Stock Value
1
AABA
Altaba Inc
AABA
+$507M
2
TSM icon
TSMC
TSM
+$49M
3
UBS icon
UBS Group
UBS
+$32.7M
4
XL
XL Group Ltd.
XL
+$28.4M
5
DB icon
Deutsche Bank
DB
+$26.9M

Sector Composition

Rank Sector Weight
1 Healthcare 15.83%
2 Technology 14.81%
3 Financials 9.13%
4 Communication Services 9.13%
5 Materials 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTLP
326
DELISTED
Cantaloupe
CTLP
$100K 0.01%
+13,827
New +$191K
NVLN
327
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$96K 0.01%
32,296
-19,266
-37% -$68.2K
IVAC
328
DELISTED
Intevac Inc
IVAC
$89K 0.01%
17,085
-39,702
-70% -$202K
RFL icon
329
Rafael Holdings
RFL
$111M
$86K 0.01%
10,418
-8,106
-44% -$73.9K
IDT icon
330
IDT Corp
IDT
$1.6B
$81K 0.01%
15,242
-40,033
-72% -$214K
DF
331
DELISTED
Dean Foods Company
DF
$72K ﹤0.01%
+10,165
New +$88.9K
NNA
332
DELISTED
Navios Maritime Acquisition Corporation
NNA
$54K ﹤0.01%
7,068
-8,394
-54% -$72.2K
CFMS
333
DELISTED
Conformis, Inc. Common Stock
CFMS
$38K ﹤0.01%
1,451
-3,902
-73% -$106K
SALM
334
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$37K ﹤0.01%
10,907
-21,372
-66% -$92.9K
AST
335
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$22K ﹤0.01%
17,168
-64,382
-79% -$100K
SHLD
336
DELISTED
Sears Holding Corporation
SHLD
$21K ﹤0.01%
+21,631
New +$36.1K
RSYS
337
DELISTED
Radisys Corp
RSYS
$20K ﹤0.01%
12,428
-97,440
-89% -$151K
CVRS
338
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$19K ﹤0.01%
13,175
-250,332
-95% -$274K
MVIS icon
339
Microvision
MVIS
$88.2M
$13K ﹤0.01%
10,495
-199,395
-95% -$208K
CLDX icon
340
Celldex Therapeutics
CLDX
$2.77B
$9K ﹤0.01%
1,363
-25,893
-95% -$181K
GNCA
341
DELISTED
Genocea Biosciences, Inc.
GNCA
$8K ﹤0.01%
1,280
-24,317
-95% -$128K
A icon
342
Agilent Technologies
A
$39.1B
-12,113
Closed -$749K
AAPL icon
343
Apple
AAPL
$4.89T
-23,944
Closed -$1.11M
ABBV icon
344
AbbVie
ABBV
$458B
-4,417
Closed -$409K
ABT icon
345
Abbott
ABT
$180B
-14,150
Closed -$863K
ADBE icon
346
Adobe
ADBE
$89.5B
-6,821
Closed -$1.66M
ADI icon
347
Analog Devices
ADI
$181B
-4,751
Closed -$456K
ADSK icon
348
Autodesk
ADSK
$44.3B
-4,594
Closed -$602K
AJG icon
349
Arthur J. Gallagher & Co
AJG
$63.7B
-25,464
Closed -$1.66M
ALTO icon
350
Alto Ingredients
ALTO
$360M
-108,047
Closed -$281K

Similar funds

LMR Partners's Q3 2018 Portfolio in Review

As of Q3 2018, LMR Partners held 618 positions worth $1.57B, down 18% from $1.93B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

LMR Partners withdrew a net $378M in Q3 2018, closing 276 positions and reducing 119 holdings. Its most notable exit was TSMC, an estimated $49M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 12% a quarter earlier, followed by Technology and Financials.

Against the trend, LMR Partners opened a new position in Express Scripts Holding Company worth $83.5M.

  • LMR Partners's largest Q3 2018 buy was Express Scripts Holding Company: 879,150 shares worth $83.5M.
  • LMR Partners added most to Twenty-First Century Fox, Inc. Class A in Q3 2018, an estimated $56.8M increase.
  • LMR Partners's biggest Q3 2018 reduction was Altaba Inc, cutting an estimated $507M.
  • LMR Partners fully exited TSMC in Q3 2018, selling an estimated $49M.
  • LMR Partners's ten largest holdings make up 34% of its $1.57B portfolio in Q3 2018.
  • LMR Partners opened 154 new positions and closed 276 in Q3 2018.
  • LMR Partners's portfolio value fell 18% quarter-over-quarter to $1.57B.

Based on LMR Partners's 13F filing for Q3 2018, filed 14 Nov 2018.